Announcement under Regulation 30 of SEBI Listing Regulations- Press Release
JAYKAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jaykay Enterprises reported exceptional Q4 FY2025-26 results with total income of ₹69.78 crore, a 322% jump from ₹16.53 crore in the same quarter last year. For the full year, total income surged 185% to ₹282.30 crore from ₹98.94 crore, while EBITDA grew 274% to ₹66.89 crore. Profit After Tax reached ₹215.65 crore for FY26. The company secured defence orders from strategic organisations including BrahMos, BDL, HAL, BEL, NSTL and ADA, and completed expansion of its Cherlapally facility in Hyderabad. In April 2026, it acquired Patange Industries for defence precision manufacturing. The medical implants unit received CDSCO certification and commenced commercial production of patient-specific implants.
The company showed dramatic revenue and profit growth driven by defence orders and new product launches. The acquisition of Patange Industries and expansion of manufacturing facilities position it for continued growth in defence and aerospace sectors, though investors should note the exceptional item of ₹262.66 crore from investment revaluation inflated PAT significantly.